NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/31/23 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 01/26/23 | EFFECT | Notice of Effectiveness |
|
1 | |
| 01/24/23 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 01/20/23 | 8-K | Current report filing |
|
   |
4 |
| 01/05/23 | UPLOAD | SEC-generated letter |
|
1 | |
| 01/03/23 | 8-K | Current report filing |
|
|
2 |
| 12/30/22 | S-3 | Registration statement for specified transactions by certain issuers |
|
100 | |
| 12/29/22 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 11/10/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
39 |
| 11/10/22 | 8-K | Current report filing |
|
|
6 |